CAS: 1220026-26-5
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | CCR1 antagonist 9 REF: 3D-VYB02626CAS: 1220026-26-5 | Min. 95% | A consultar | Jue 13 Jun 24 |
 | CCR1 antagonist 9 REF: TM-T10710CAS: 1220026-26-5 | - - - | 95,00 €~1.507,00 € | Jue 20 Jun 24 |
CCR1 antagonist 9
CAS:1220026-26-5
CCR1 antagonist 9 is a peptide that is used as a research tool for studying …
Fórmula:
C20H16FN5O3S
Pureza:
Min. 95%
Peso molecular:
425.4 g/mol
Ref: 3D-VYB02626
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 13 de Junio de 2024
CCR1 antagonist 9
CAS:1220026-26-5
CCR1 antagonist 9 is an effective and selective CCR1 antagonist (IC50: 6.8 nM in calcium …
Fórmula:
C20H16FN5O3S
Peso molecular:
425.44
Ref: TM-T10710
| 5mg | 243,00 € | |
| 25mg | 792,00 € | |
| 50mg | 1.039,00 € | |
| 100mg | 1.507,00 € | |
| 1ml*10 (DMSO) | 293,00 € |
Entrega estimada en Estados Unidos, el Jueves 20 de Junio de 2024
